VTAK

Catheter Precision Inc

Add to Watchlist

Advanced Chart

0.177

+0.004(2.312%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

0.179

Open

0.1755

VWAP

0.18

Vol

378.74K

Mkt Cap

4.04M

Low

0.1711

Amount

66.39K

EV/EBITDA(TTM)

Total Shares

7.57M

5.98M

EV/OCF(TTM)

P/S(TTM)

2.61

Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.

Unlock Winning Stocks with Intellectia.AI

Trusted by 300K+ investors. Get AI-driven trading signals to seize opportunities fast!

Unlock Winning Stocks with Intellectia.AI

Trusted by 300K+ investors. Get AI-driven trading signals to seize opportunities fast!

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q1

FY2025Q2

310.00K

+278.05%

-0.200

-94.44%

600.00K

+545.16%

-0.180

-96.77%

Estimates Revision

The market is revising No Change the revenue expectations for Catheter Precision, Inc. (VTAK) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -42.25%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-42.25%

In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Catheter Precision Inc (VTAK.A) is -0.28, compared to its 5-year average forward P/E of -0.30. For a more detailed relative valuation and DCF analysis to assess Catheter Precision Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-0.30

Current PE

-0.28

Overvalued PE

-0.02

Undervalued PE

-0.58

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

0.52

Current PS

0.63

Overvalued PS

1.04

Undervalued PS

0.01

Intellectia.AI: Your Edge in Stock Trading

Join 300K+ users and access AI-powered stock picks that spot trends in minutes!

Intellectia.AI: Your Edge in Stock Trading

Join 300K+ users and access AI-powered stock picks that spot trends in minutes!

Financials

Annual

Quarterly

FY2025Q2

YoY :

+127.96%

212.00K

Total Revenue

FY2025Q2

YoY :

+4.45%

-2.84M

Operating Profit

FY2025Q2

YoY :

+51.85%

-6.41M

Net Income after Tax

FY2025Q2

YoY :

-93.18%

-0.38

EPS - Diluted

FY2025Q2

YoY :

+30.65%

-2.28M

Free Cash Flow

FY2025Q2

YoY :

+12.80%

93.40

Gross Profit Margin - %

FY2025Q2

YoY :

+0.12%

-1.71K

FCF Margin - %

FY2025Q2

YoY :

-43.26%

-2.57K

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

1.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

0.0

Volume

6-9

Months

0.0

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

0.0

Volume

Months

6-9

0.0

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

1.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Trade Smarter with Intellectia.AI

300K+ trust us for AI trading signals that capture market momentum early!

Trade Smarter with Intellectia.AI

300K+ trust us for AI trading signals that capture market momentum early!

VTAK News & Events

Events Timeline

2025-08-13 (ET)

2025-08-13

08:19:05

New

Catheter Precision announces first LockeT cases completed in Germany

2025-08-11 (ET)

2025-08-11

08:02:40

Catheter Precision reports Q2 revenue $212,000 vs. $93,000 last year

2025-08-07 (ET)

2025-08-07

08:24:13

Catheter Precision: Heart Hospital completes 200 ablation procedures with VIVO

News

9.0

08-10TipRanks

Upcoming Stock Splits This Week (August 11 to August 15) – Stay Invested

2.0

06-16Benzinga

Why Incyte Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

2.0

06-12Newsfilter

Catheter Precision, Inc. Comments on Recent Market Activity

People Also Watch

InMed Pharmaceuticals Inc

Reliance Global Group Inc

NovaBay Pharmaceuticals Inc

Zyversa Therapeutics Inc

Enveric Biosciences Inc

American Rebel Holdings Inc

FAQ

What is Catheter Precision Inc (VTAK) stock price today?

The current price of VTAK is 0.1773 USD — it has increased 2.31 % in the last trading day.

VTAK

Unlock Winning Stocks with Intellectia.AI

Unlock Winning Stocks with Intellectia.AI

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Intellectia.AI: Your Edge in Stock Trading

Intellectia.AI: Your Edge in Stock Trading

Financials

Trading Trends

Trade Smarter with Intellectia.AI

Trade Smarter with Intellectia.AI

VTAK News & Events

Events Timeline

News

People Also Watch

FAQ

What is Catheter Precision Inc (VTAK) stock price today?

What is Catheter Precision Inc (VTAK)'s business?

What is the price predicton of VTAK Stock?

What is Catheter Precision Inc (VTAK)'s revenue for the last quarter?

What is Catheter Precision Inc (VTAK)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Catheter Precision Inc (VTAK)'s fundamentals?

How many employees does Catheter Precision Inc (VTAK). have?

What is Catheter Precision Inc (VTAK) market cap?